Early Symptoms of Gastric Malignancy
The early symptoms of gastric cancer are predominantly non-specific dyspepsia without alarm features, making early detection challenging—approximately 70% of patients with early gastric cancer present with uncomplicated dyspeptic symptoms alone, without anemia, dysphagia, or weight loss 1.
Key Clinical Presentation Patterns
Early-Stage Disease (Often Asymptomatic)
- Dyspepsia is the dominant symptom in early gastric cancer, indistinguishable from benign peptic ulcer disease 2, 3
- Most patients are either completely asymptomatic or have long-standing, non-specific upper abdominal discomfort 3
- Critical pitfall: The absence of alarm symptoms does NOT exclude malignancy—alarm symptoms typically indicate advanced, often inoperable disease 4, 3
Symptomatic Presentation (More Advanced Disease)
When symptoms do occur, the most common presenting features include 5:
- Weight loss (63-74% of cases)
- Dyspepsia/epigastric pain (74%)
- Early satiety
- Vomiting
- Iron-deficiency anemia (43% with gastrointestinal bleeding)
- Dysphagia (particularly with proximal/cardia tumors)
Critical Clinical Considerations
The Diagnostic Dilemma
Clinical diagnosis is highly inaccurate in distinguishing organic from non-organic disease 1. The use of alarm symptoms alone to select patients for endoscopy causes patients with localized, potentially curable disease to be overlooked 1. This creates a paradox: early cancers lack distinctive symptoms, while the presence of alarm symptoms often signals advanced disease.
Who Requires Endoscopy
Based on the strongest guideline evidence 1:
- All patients ≥55 years with new-onset dyspepsia (persistent symptoms <1 year duration)
- Any age with alarm features: weight loss, anemia, anorexia, dysphagia, vomiting, jaundice, or palpable abdominal mass
- Patients with clinical suspicion of malignancy even without alarm features
- High-risk individuals ≥45 years with multiple risk factors (H. pylori infection, family history, smoking, high-risk ethnicity) 6
The Proton Pump Inhibitor Problem
A major diagnostic barrier: Widespread PPI prescription can heal malignant ulcers and diminish symptoms, making gastric cancers more difficult to identify both clinically and endoscopically 3. This delays diagnosis and allows progression to more advanced stages.
Prognostic Significance of Symptoms
When symptoms are present at diagnosis, they carry prognostic weight 4:
- Major independent poor prognostic factors: Dysphagia, weight loss, palpable abdominal mass
- Less prognostic impact: Gastrointestinal bleeding, vomiting, symptom duration
- Increased number of alarm symptoms correlates with higher risk of death
Practical Approach
The key message: Do not wait for alarm symptoms to pursue endoscopic evaluation. The median symptom duration before diagnosis is 12 months 7, and early gastric cancer confined to mucosa/submucosa has >90% 5-year survival 2, compared to 10% for late-stage disease in Western countries 3.
Maintain high clinical suspicion in patients >55 years with persistent dyspepsia, even when "uncomplicated," and consider endoscopy liberally in high-risk populations regardless of symptom severity. The detection rate is only 1-3% 1, but the mortality benefit of early detection is substantial.